Estimating the Survival of Patients With Lung Cancer: What Is the Best Statistical Model?-Reference-Cited by-同舟云学术

Estimating the Survival of Patients With Lung Cancer: What Is the Best Statistical Model?

Published:2019-03-31 Issue:2 Volume:52 Page:140-144
ISSN:1975-8375
Container-title:Journal of Preventive Medicine and Public Health
language:en
Short-container-title:J Prev Med Public Health

Author:

Abedi Siavosh^ORCID,Janbabaei Ghasem^ORCID,Afshari Mahdi^ORCID,Moosazadeh Mahmood^ORCID,Rashidi Alashti Masoumeh^ORCID,Hedayatizadeh-Omran Akbar^ORCID,Alizadeh-Navaei Reza^ORCID,Abedini Ehsan^ORCID

Publisher

Korean Society for Preventive Medicine

Subject

Public Health, Environmental and Occupational Health

Link

http://jpmph.org/upload/pdf/jpmph-52-2-140.pdf

Reference13 articles.

1. Estimation of Survival Rates in Patients with Lung Cancer in West Azerbaijan, the Northwest of Iran

2. Epidemiology, incidence and mortality of lung cancer and their relationship with the development index in the world

3. Survival of patients with small cell lung cancer undergoing lung resection in England, 1998–2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung Cancer Survival Time Prediction Using Machine Learning and Deep Learning Techniques;2023 Fourth International Conference on Intelligent Data Science Technologies and Applications (IDSTA);2023-10-24

2. Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer;BMC Cancer;2022-09-21

3. Primary and Acquired Resistance against Immune Check Inhibitors in Non-Small Cell Lung Cancer;Cancers;2022-07-06

4. Impact of Residential Concentration of PM2.5 Analyzed as Time-Varying Covariate on the Survival Rate of Lung Cancer Patients: A 15-Year Hospital-Based Study in Upper Northern Thailand;International Journal of Environmental Research and Public Health;2022-04-08

5. Risk factors of inability to live independently in the course of lung cancer;Postępy Higieny i Medycyny Doświadczalnej;2022-01-01